Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Knowing when to choose investing over saving can significantly enhance your wealth. Discover strategies to make informed financial decisions.
23,985 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
The latest NY Fed report shows total household debt at $18.8 trillion by year-end 2025, with stronger paychecks not r...
NVIDIA just crushed earnings on the headline numbers, yet the stock reacted oddly, slipping the next day. This guide ...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
When the market opened on Wednesday, Jabil shares surged as investors digested stronger-than-expected Q3 results and ...
SpaceX captures headlines with bold tech and presumed multi-bagger upside. Still, the stock question isn’t simple. Th...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
In March 2026, investors seek cost-efficient, user-friendly options beyond M1 Finance. This report breaks down the to...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Retail traders are adopting a pared-down framework called the three-circle test: don’t need to be a CEO to pick winni...
Quantum stocks are on a rebound after a rough patch. This guide breaks down why ionq, rigetti, d-wave surging matters...